Description |
ATPase cation transporting 13A2 |
neurexin 1 |
Image |
No pdb structure |
|
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Body fat distribution (arm fat ratio) ( 30664634)
- Body fat distribution (leg fat ratio) ( 30664634)
- Body fat distribution (trunk fat ratio) ( 30664634)
- Brain morphology (min-P) ( 32665545)
- Brain morphology (MOSTest) ( 32665545)
- Cortical surface area (min-P) ( 32665545)
- Cortical surface area (MOSTest) ( 32665545)
- Cortical thickness (min-P) ( 32665545)
- Cortical thickness (MOSTest) ( 32665545)
- Height ( 25429064 31562340 20189936)
- Hemoglobin levels ( 32327693)
- Hip circumference adjusted for BMI ( 28552196 25673412)
- Intraocular pressure ( 29617998)
- Subcortical volume (min-P) ( 32665545)
- Subcortical volume (MOSTest) ( 32665545)
- Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) ( 28448500)
- Waist circumference adjusted for BMI in active individuals ( 28448500)
- Waist circumference adjusted for body mass index ( 28552196)
|
- Adult body size ( 32376654)
- Body mass index ( 28892062)
- Chromosomal aberration frequency (chromatid type) ( 31586183)
- Chronotype ( 30696823)
- Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203)
- Educational attainment ( 25201988)
- General risk tolerance (MTAG) ( 30643258)
- Isovolumetric relaxation time ( 28394258)
- Lateral ventricle temporal horn volume ( 31530798)
- Longevity ( 20834067)
- Lung cancer in ever smokers ( 28604730)
- Metabolite levels (HVA/MHPG ratio) ( 23319000)
- Morning person ( 30696823)
- Nicotine dependence symptom count ( 25555482)
- Personality dimensions ( 20691247)
- Post bronchodilator FEV1/FVC ratio ( 26634245)
- Refractive astigmatism ( 25367360)
- Response to zileuton treatment in asthma (FEV1 change interaction) ( 26031901)
- Severe gingival inflammation ( 28459102)
- Systolic blood pressure ( 30224653 30578418)
- Temperament ( 22832960)
- Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes ( 28736931)
- Triglyceride levels ( 32203549)
- Word spelling ( 30741946)
|
Interacting Genes |
36 interacting genes:
ACKR3
ATP5MC2
CCKBR
CMTM6
COL1A1
CXCR4
CYGB
DCAF7
EMC7
F2R
FAM111B
FAM8A1
FKBP8
FUNDC2
GPR21
HIPK1
ICAM2
LMAN2
LRP6
MEX3B
MYCBP2
NPY1R
NRXN1
OCA2
OSTC
PCDHB10
PCMTD2
PDIA6
PSME3IP1
SEC61B
SPCS2
TSPAN14
UBE2J2
VAMP2
WDR5B
WDR83OS
|
28 interacting genes:
AFDN
APBA1
APBA2
ATP13A2
CASK
MACF1
MYO16
NLGN1
NLGN2
NLGN3
NXPH1
NXPH2
NXPH3
PDZD2
RPH3A
SDCBP2
SIPA1L1
SYT1
SYT13
SYT2
SYT4
SYT5
SYT6
SYT7
SYT9
SYTL1
SYTL2
SYTL3
|
Entrez ID |
23400 |
9378 |
HPRD ID |
13677 |
11858 |
Ensembl ID |
ENSG00000159363
|
ENSG00000179915
|
Uniprot IDs |
Q8N4D4
Q8NBS1
Q9NQ11
|
A0A0D9SEM5
A0A0D9SEQ7
A0A1D5RMU6
E7EQN4
E7ERL8
H0Y568
H7BYC7
P58400
Q9ULB1
|
PDB IDs |
|
3B3Q
5Z8Y
6NID
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|